Reaction
Corneal Perforation reporting signals
As of the last recalculation, Corneal Perforation appears in 613 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is MOXIFLOXACIN HYDROCHLORIDE (PRR 91.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Moxifloxacin Hydrochloride | 50 | 91.1 | 91.3 |
| Moxifloxacin | 32 | 81.3 | 81.5 |
| Tobramycin Sulfate | 27 | 77.4 | 77.6 |
| Tobramycin Solution | 25 | 73.6 | 73.8 |
| Prednisolone Acetate | 20 | 67.8 | 67.9 |
| Cenegermin-Bkbj | 21 | 61.0 | 61.1 |
| Atropine Sulfate | 14 | 45.0 | 45.1 |
| Atropine | 10 | 41.6 | 41.7 |
| Tobramycin | 26 | 38.3 | 38.3 |
| Voriconazole Injection | 23 | 37.3 | 37.4 |
| Daspone | 8 | 28.2 | 28.3 |
| Dapsone Gel, 5% | 8 | 28.2 | 28.3 |
| Voriconazole | 24 | 27.9 | 27.9 |
| Ganciclovir | 8 | 26.9 | 26.9 |
| Itraconazole | 9 | 26.5 | 26.6 |
| Dapsone | 8 | 25.8 | 25.8 |
| Ganciclovir Sodium | 7 | 22.7 | 22.7 |
| Amphotericin B | 8 | 22.0 | 22.0 |
| Carboxymethylcellulose Sodium | 6 | 21.9 | 21.9 |
| Dorzolamide Hydrochloride And Timolol Maleate | 5 | 21.6 | 21.7 |
| Erlotinib | 6 | 21.2 | 21.2 |
| Erlotinib Hydrochloride | 6 | 16.4 | 16.4 |
| Brimonidine Tartrate | 8 | 15.4 | 15.4 |
| Durvalumab | 5 | 8.4 | 8.4 |
| Lifitegrast | 4 | 8.4 | 8.4 |